|
|||||||
|
 |
Dr. Billings is Vice President for Life Sciences and Clinical Affairs for WIPRO, Ltd., via its subsidiary WIPRO HealthScience (www.wipro.com/healthcare). He is also a Co-Founder of GeneSage, Inc. (www.genesage.com) where he recently acted as Executive Vice President and Chief Scientific and Medical Officer. He has been Editor-in-Chief of GeneSage’s GeneLetter (www.GeneLetter.com), the leading on-line magazine of genetic medicine, society and culture. In addition, Dr. Billings is an Adjunct Professor in the Department of Anthropology at the University of California at Berkeley and is Co-Principal Investigator on a Robert Wood Johnson Foundation funded project studying the impact of genomic medicine on health care. WIPRO, with over fourteen thousand employees and revenues in excess of $1 billion annually, is a global consulting and information technology company (NYSE: wit) that provides products and services to improve the efficiency and quality of healthcare. GeneSage is a new company that seeks to translate the promise of progress in human genetics in to solutions for health care providers and consumers. Prior to assuming his current responsibilities, Dr. Billings was Deputy Network Director and Chief Medical Officer of the Heart of Texas Veterans Health Care System. In Texas, Dr. Billings’ duties included insuring high quality health care for over 1 million eligible patients and supervising 3 integrated medical staffs of over 700 physicians. In addition, he directly oversaw nearly 30 million dollars of peer-reviewed research and supervised the training of approximately 300 medical residents in collaboration with 3 major university affiliates. Dr. Billings has devoted more than 10 years of his professional career to the health care of veterans and other needy populations. To his corporate and clinical activities , Dr. Billings brings his expertise in clinical genetics, the genetics of common diseases, the influence of genetic technology on society, and the biology and health impacts of stem cells. He is also an internationally recognized authority on genetic discrimination. Dr. Billings has been a member of the faculties at Harvard Medical School, the University of California at San Francisco, Stanford University and the University of California at Berkeley. He has also served as Chief of the Division of Genetic Medicine and Vice-Chairman of the Department of Medicine at Pacific Presbyterian Medical Center in San Francisco (now called the California Pacific Medical Center) where he founded the Center for Inherited Diseases and led the Program in Genetics and Society, the Center for Adults with Cystic Fibrosis, the Breast Cancer Risk Assessment and Management Program, as well as the Prenatal Diagnostic Center at Alta Bates Hospital. Dr. Billings has published over 130 scholarly articles and book c hapters in addition to his book, DNA on Trial: Genetic Identification and Criminal Justice. He was a member of the Joint NIH/DOE Task Force on Genetic Information and Insurance, has been a technical advisor to the National Association of Insurance Commissioners and the NIH/FDA Recombinant DNA Advisory Committee, and has testified on many occasions to the United States Congress and to state legislatures on issues involving human genetics. His work and comments appear frequently in all major popular media. Dr. Billings received his MD and PhD degrees from Harvard University in 1979. His thesis advisor was Nobel Laureate, Baruj Benacerraf, MD. He completed his clinical training in Internal Medicine and Medical Genetics at the University of Washington in Seattle in 1983. He is a Founding Fellow of the American College of Medical Genetics, a Fellow of the American College of Physicians and a Distinguished Lecturer for the national science society, Sigma Xi. He chairs the Medical Advisory Board of Cord Blood Registry, Inc. where he previously was Medical Director, and the Board of Directors of the Alpha-1 Association and the Council for Responsible Genetics. He is also a member of the Board of Directors of the Cord Blood Donor Foundation and the Cardiac Arrhythmia Research and Education Foundation. He currently provides advice on research and development to many large companies in the Life Sciences and Pharma sectors and is an active affiliate of the Institute for the Future.
|
|
|
|
|
 |
|
|
